Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories.


Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
07 2020
Historique:
received: 02 05 2020
accepted: 09 05 2020
pubmed: 15 5 2020
medline: 7 7 2020
entrez: 15 5 2020
Statut: ppublish

Résumé

With emergence of pandemic COVID-19, rapid and accurate diagnostic testing is essential. This study compared laboratory-developed tests (LDTs) used for the detection of SARS-CoV-2 in Canadian hospital and public health laboratories, and some commercially available real-time RT-PCR assays. Overall, analytical sensitivities were equivalent between LDTs and most commercially available methods.

Identifiants

pubmed: 32405254
doi: 10.1016/j.jcv.2020.104433
pii: S1386-6532(20)30175-X
pmc: PMC7219382
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104433

Informations de copyright

Crown Copyright © 2020. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts to declare

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Clin Microbiol. 2013 Nov;51(11):3835-8
pubmed: 23966485
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32132196
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
J Clin Microbiol. 2015 May;53(5):1748-51
pubmed: 25740765
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Mil Med Res. 2020 Feb 6;7(1):4
pubmed: 32029004

Auteurs

Jason J LeBlanc (JJ)

Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health Authority (NSHA), Room 404B, MacKenzie Building, 5788 University Avenue, Halifax, Nova Scotia B3H 1V8, Canada; Departments of Pathology, Medicine, and Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: jason.leblanc@nshealth.ca.

Jonathan B Gubbay (JB)

Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Public Health Ontario Laboratories, Toronto, Ontario, Canada; Hospital for Sick Children, Toronto, Ontario, Canada.

Yan Li (Y)

National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), Winnipeg, Manitoba, Canada.

Robert Needle (R)

Public Health and Microbiology Laboratory, St. John's, Newfoundland, Canada.

Sandra Radons Arneson (SR)

National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), Winnipeg, Manitoba, Canada.

Dionne Marcino (D)

National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), Winnipeg, Manitoba, Canada.

Hugues Charest (H)

Laboratoire De Santé Publique Du Québec/INSPQ, Sainte-Anne-de-Bellevue, Quebec, Canada.

Guillaume Desnoyers (G)

Centre Hospitalier Universitaire Dr. Georges L. Dumont, Moncton, New-Brunswick, Canada.

Kerry Dust (K)

Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada.

Ramzi Fattouh (R)

Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.

Richard Garceau (R)

Centre Hospitalier Universitaire Dr. Georges L. Dumont, Moncton, New-Brunswick, Canada.

Gregory German (G)

Queen Elizabeth Hospital, Charlottetown, Prince Edward Island, Canada.

Todd F Hatchette (TF)

Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health Authority (NSHA), Room 404B, MacKenzie Building, 5788 University Avenue, Halifax, Nova Scotia B3H 1V8, Canada; Departments of Pathology, Medicine, and Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.

Robert A Kozak (RA)

Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Research Institute, Toronto, Ontario, Canada.

Mel Krajden (M)

Public Health Laboratory, British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia, Canada.

Theodore Kuschak (T)

National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), Winnipeg, Manitoba, Canada.

Amanda L S Lang (ALS)

Roy Romanow Provincial Laboratory (RRPL), Saskatchewan Health Authority (SHA), Regina, Saskatchewan, Canada.

Paul Levett (P)

Public Health Laboratory, British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia, Canada.

Tony Mazzulli (T)

Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada.

Ryan McDonald (R)

Roy Romanow Provincial Laboratory (RRPL), Saskatchewan Health Authority (SHA), Regina, Saskatchewan, Canada.

Samira Mubareka (S)

Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Research Institute, Toronto, Ontario, Canada.

Natalie Prystajecky (N)

Public Health Laboratory, British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia, Canada.

Candy Rutherford (C)

St Joseph's Healthcare, Hamilton, Ontario, Canada.

Marek Smieja (M)

St Joseph's Healthcare, Hamilton, Ontario, Canada.

Yang Yu (Y)

Public Health and Microbiology Laboratory, St. John's, Newfoundland, Canada.

George Zahariadis (G)

Public Health and Microbiology Laboratory, St. John's, Newfoundland, Canada.

Nathan Zelyas (N)

Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health Authority (NSHA), Room 404B, MacKenzie Building, 5788 University Avenue, Halifax, Nova Scotia B3H 1V8, Canada; Provincial Laboratory for Public Health (ProvLab), Calgary, Alberta, Canada.

Nathalie Bastien (N)

National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH